Background Few studies have focused on the relationship between the traditional Chinese
medicine constitution (TCMC) and metabolic dysfunction-associated fatty liver disease …

Background: The coronavirus pandemic has led to the creation of clinical guidelines by a
large number of professional medical communities. However, the quality and methodology …

Background The extent to which differences in results from Apixaban for Reduction in Stroke
and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) and Rivaroxaban Once …

Background: Real-world evidence on direct oral anticoagulant outcomes among Non-
Valvular Atrial Fibrillation (NVAF) patients is limited. We aimed to evaluate stroke/systemic …

Aims Direct oral anticoagulant (DOAC) is widely used for the prevention of embolic stroke in
non-valvular atrial fibrillation (NVAF) patients. However, the gastrointestinal bleeding risk in …

Background and purpose Atrial fibrillation-related stroke (AF-stroke) is associated with an
adverse prognosis, characterized by a high incidence of progression, recurrence, and …

Background For patients anticoagulated with direct oral anticoagulants (DOAC) or warfarin
and on aspirin (ASA) for non-valvular atrial fibrillation (AF) and/or venous thromboembolism …

Objectives Bleeding after endoscopic submucosal dissection (ESD) for gastric tumors in
patients taking antithrombotic drugs, in particular direct oral anticoagulants (DOACs) …

First, this cluster randomized clinical trial1 included a total of 1049 participants across 43 US
cardiology clinics, and the clinics were randomized rather than the participants. Due to the …

The efficacy and safety of anticoagulant therapy in patients with acute ischemic stroke (AIS)
and atrial fibrillation (AF) remain uncertain. This study enrolled 431 AIS and AF patients from …